Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
José Adão Carvalho Nascimento Júnior, Anamaria Mendonça Santos, Lucindo José Quintans‐Júnior, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 8, pp. 567-579
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100719-100719
Open Access | Times Cited: 170
Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review
Shabnam Ghahremanian, Mohammad Mehdi Rashidi, Kimai Raeisi, et al.
Journal of Molecular Liquids (2022) Vol. 354, pp. 118901-118901
Open Access | Times Cited: 129
Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease
Kamrul Hasan Chowdhury, Md. Riad Chowdhury, Shafi Mahmud, et al.
Biology (2020) Vol. 10, Iss. 1, pp. 2-2
Open Access | Times Cited: 82
Repurposing drugs for the management of COVID-19
Jacopo Cusinato, Ylenia Cau, Anna Maria Calvani, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 4, pp. 295-307
Closed Access | Times Cited: 76
Development of vaccine formulations: past, present, and future
Carmine D’Amico, Flavia Fontana, Ruoyu Cheng, et al.
Drug Delivery and Translational Research (2021) Vol. 11, Iss. 2, pp. 353-372
Open Access | Times Cited: 71
A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics
Jonas Goßen, Simone Albani, Anton Hanke, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 3, pp. 1079-1095
Open Access | Times Cited: 59
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
Hooman Aghamirza Moghim Aliabadi, Reza Eivazzadeh‐Keihan, Arezoo Beig Parikhani, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 44
Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26
Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Daniela Spano, Giuliana Catara
Cells (2023) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 23
The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options
Arezoo Beig Parikhani, Masoume Bazaz, Hadi Bamehr, et al.
Current Microbiology (2021) Vol. 78, Iss. 4, pp. 1099-1114
Open Access | Times Cited: 43
In silico Studies on the Interaction between Mpro and PLpro From SARS‐CoV‐2 and Ebselen, its Metabolites and Derivatives
Pablo A. Nogara, Folorunsho Bright Omage, Gustavo Roni Bolzan, et al.
Molecular Informatics (2021) Vol. 40, Iss. 8
Open Access | Times Cited: 39
Review of the Crystallized Structures of the SARS-CoV-2 papain-like protease
Yue Qiu, Jiang Hua-Juan, Yang Yu-Shun, et al.
Journal of Molecular Structure (2025), pp. 141730-141730
Closed Access
In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication
Cássia P. Delgado, Pablo A. Nogara, Milene Dias Miranda, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 491-491
Open Access
Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2
Muhammad Arba, Setyanto Tri Wahyudi, Dylan Brunt, et al.
Computers in Biology and Medicine (2020) Vol. 129, pp. 104156-104156
Open Access | Times Cited: 35
2D materials as a diagnostic platform for the detection and sensing of the SARS-CoV-2 virus: a bird's-eye view
Pranay Ranjan, Vinoy Thomas, Prashant Kumar
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 23, pp. 4608-4619
Open Access | Times Cited: 31
A Patent Review on SARS Coronavirus Main Protease (3CLpro) Inhibitors
C. S. Brian Chia, Weijun Xu, Pearly Shuyi Ng
ChemMedChem (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 30
Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review
Mohd Imran, Ahmed Subeh Alshrari, Syed Mohammed Basheeruddin Asdaq, et al.
Journal of Infection and Public Health (2021) Vol. 14, Iss. 8, pp. 1075-1086
Open Access | Times Cited: 28
In-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro PDB ID:5R83) using a virtual screening method
Ahmed Boufissiou, Mohnad Abdalla, Mohamed Sharaf, et al.
Journal of Saudi Chemical Society (2022) Vol. 26, Iss. 3, pp. 101473-101473
Open Access | Times Cited: 20
A small interfering RNA (siRNA) database for SARS-CoV-2
Inácio Gomes Medeiros, André Salim Khayat, Beatriz Stransky, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Network analytics for drug repurposing in COVID-19
Nicoleta Siminea, Victor Popescu, José Ángel Sánchez Martín, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
Sajjad Ahmad, Yasir Waheed, Saba Ismail, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1446-1446
Open Access | Times Cited: 23
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV.
Rajat Goyal, Rupesh K. Gautam, Hitesh Chopra, et al.
PubMed (2022) Vol. 21, pp. 1245-1272
Closed Access | Times Cited: 17
Discovery of small molecule PLpro inhibitor against COVID-19 using structure-based virtual screening, molecular dynamics simulation, and molecular mechanics/Generalized Born surface area (MM/GBSA) calculation
Jie Pang, Shan Gao, Zengxian Sun, et al.
Structural Chemistry (2020) Vol. 32, Iss. 2, pp. 879-886
Open Access | Times Cited: 25
Use of nanotechnology applied to sunscreens: Technological prospection based on patents
José Adão Carvalho Nascimento Júnior, Anamaria Mendonça Santos, Ana Maria Santos Oliveira, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105245-105245
Closed Access | Times Cited: 8
Searching and Analyzing Patent-relevant COVID-19 Information
Luca Falciola, Massimo Barbieri
World Patent Information (2022) Vol. 68, pp. 102094-102094
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top